The purpose of this trial is to study the safety of an investigational drug on insomnia in the elderly.

Condition	Treatment or Intervention	Phase
Insomnia		Phase II Phase III

Ages Eligible for Study:  65 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• Diagnosis of Insomnia

Toll Free Number      1-888-577-8839 

Arkansas
      Call for Information, Little Rock,  Arkansas,  72223,  United States; Recruiting
California
      Call for Information, San Diego,  California,  92108,  United States; Recruiting
      Call for Information, Redlands,  California,  92374,  United States; Recruiting
      Call for Information, El Centro,  California,  92243,  United States; Recruiting
      Call for Information, Fresno,  California,  93720,  United States; Recruiting
      Call for Information, Oceanside,  California,  92056,  United States; Recruiting
      Call for Information, La Mesa,  California,  91942,  United States; Recruiting
Colorado
      Call for Information, Denver,  Colorado,  80212,  United States; Recruiting
Connecticut
      Call for Information, Stratford,  Connecticut,  06615,  United States; Recruiting
Florida
      Call for Information, Stuart,  Florida,  34996,  United States; Recruiting
      Call for Information, Pembroke Pines,  Florida,  33024,  United States; Recruiting
      Call for Information, West Palm Beach,  Florida,  33407,  United States; Recruiting
      Call for Information, Jacksonville,  Florida,  32257,  United States; Recruiting
      Call for Information, North Miami,  Florida,  33161,  United States; Recruiting
      Call for Information, Tampa,  Florida,  33614,  United States; Recruiting
      Call for Information, Vero Beach,  Florida,  32960,  United States; Recruiting
      Call for Information, Coral Springs,  Florida,  33065,  United States; Recruiting
      Call for Information, St. Petersburg,  Florida,  33702,  United States; Recruiting
      Call for Information, Fort Myers,  Florida,  33912,  United States; Recruiting
Illinois
      Call for Information, Edwardsville,  Illinois,  62025,  United States; Recruiting
Maryland
      Call for Information, Rockville,  Maryland,  20852,  United States; Recruiting
      Call for Information, Baltimore,  Maryland,  21208,  United States; Recruiting
Massachusetts
      Call for Information, Belmont,  Massachusetts,  02478,  United States; Recruiting
Minnesota
      Call for Information, St. Paul,  Minnesota,  55101,  United States; Recruiting
Mississippi
      Call for Information, Ridgeland,  Mississippi,  39157,  United States; Recruiting
Missouri
      Call for Information, Kansas City,  Missouri,  64114,  United States; Recruiting
      Call for Information, St. Charles,  Missouri,  63301,  United States; Recruiting
New Mexico
      Call for Information, Albuquerque,  New Mexico,  87108,  United States; Recruiting
New York
      Call for Information, Rochester,  New York,  14609,  United States; Recruiting
      Call for Information, New York,  New York,  10023,  United States; Recruiting
Ohio
      Call for Information, Toledo,  Ohio,  43623,  United States; Recruiting
      Call for Information, Dayton,  Ohio,  45408,  United States; Recruiting
Oregon
      Call for Information, Eugene,  Oregon,  97401,  United States; Recruiting
Pennsylvania
      Call for Information, Philadelphia,  Pennsylvania,  19115,  United States; Recruiting
South Carolina
      Call for Information, Columbia,  South Carolina,  29201,  United States; Recruiting
Tennessee
      Call for Information, Memphis,  Tennessee,  38119,  United States; Recruiting
Texas
      Call for Information, Irving,  Texas,  75062,  United States; Recruiting
Utah
      Call for Information, Salt Lake City,  Utah,  84107,  United States; Recruiting
Virginia
      Call for Information, Charlottesville,  Virginia,  22903,  United States; Recruiting

Study ID Numbers:  2004_088
Record last reviewed:  March 2005
Last Updated:  March 21, 2005
Record first received:  October 29, 2004
ClinicalTrials.gov Identifier:  NCT00095043
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08